An indicative announcement by Dashenlin Pharmaceutical Group Co., Ltd. on the “Dashen Convertible Bonds” expected to meet the revised conditions for the share conversion price

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.